Saint Novel Biotech Limited

Saint Novel Biotech Limited is an AI-driven drug discovery company that leverages a proprietary 'Biology Evolution Knowledgegraph' and generative AI to accelerate the drug development process. Their platform covers the entire spectrum from target identification to clinical candidate selection, claiming to reduce development time by up to 80% and costs by 70%. The company offers end-to-end solutions including multi-omics data integration, de novo molecule design, virtual screening, and AI-driven protein/antibody engineering. They also maintain an AI-guided autonomous laboratory and provide access to humanized preclinical models to de-risk therapeutic candidates before clinical entry.